PomDoctor Limited (POM)

PomDoctor Income Statement

Financials in millions CNY. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022
Revenue	327.19	304.85	245.22
Revenue Growth (YoY)	-	24.32%	-
Cost of Revenue	-	266.13	190.36
Gross Profit	43.5	38.72	54.86
Selling, General & Admin	-	55.99	54.87
Research & Development	-	3.37	3.59
Other Operating Expenses	0	1.61	0
Operating Expenses	-	60.97	58.46
Operating Income	-18.4	-22.25	-3.59
Interest Expense / Income	-	13.85	16.02
Other Expense / Income	10.87	0.85	0.21
Pretax Income	-138.03	-145.39	-125.51
Net Income	-29.27	-36.95	-19.83
Net Income Common	-138.03	-145.39	-125.51
Free Cash Flow	-27.17	-45.91	-22.02
Gross Margin	13.29%	12.70%	22.37%
Operating Margin	-5.62%	-7.30%	-1.47%
Profit Margin	-42.19%	-47.69%	-51.18%
Free Cash Flow Margin	-8.30%	-15.06%	-8.98%
EBITDA	-	-22.99	-3.81
EBITDA Margin	-	-7.54%	-1.55%
Depreciation & Amortization	-	0.11	-
EBIT	-	-23.1	-3.81
EBIT Margin	-	-7.58%	-1.55%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).